QMS Medical Allied Services Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹53 Cr +17.5% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
QM

QMS Medical Allied Services Ltd

Q2 FY26Healthcare Equipment & Supplies

QMS Medical Allied Services Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹45Cr
+20.2% YoY
−3.9% QoQ
Net profit
₹4Cr
−15.4% YoY
+13.3% QoQ
Margin
15.48%
−4 pp YoY
+1.4 pp QoQ
Price₹148
Market cap₹216 Cr
P/E21.4

The short version

Product side growth expected around 10% to 12% annually, aligned with pharma industry growth (Page 12). Product segment expected to grow at 10-12% annually, aligned with pharma industry growth.

From QMS Medical Allied Services Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Product side growth expected around 10% to 12% annually, aligned with pharma industry growth (Page 12).
  • Service sector anticipated to grow at a faster rate, potentially doubling the growth rate of products, around 20-25% (Page 13).
  • Overall revenue growth driven significantly by patient service programs expansion and new service launches (Page 12).
  • Increase in healthcare camps with approximately 33,000 camps expected annually, maintaining or slightly increasing volumes (Page 9).
  • Expansion plans include widening market reach in India and pilot projects for Asia-Pacific expansion in 5-10 years (Page 10).

2 more points from QMS Medical Allied Services Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what QMS Medical Allied Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company is investing heavily in infrastructure and people to support growth and improve margins; these investments are expected to show results from next year onwards.
  • Investments are being made in technology adoption, capability building, brand building, field force expansion, and operational discipline.
  • Focus on integrating AI into analytics and CRM systems is underway, with plans to expand AI usage for treatment insights and market data analytics in the future.
  • Increasing field force numbers to scale healthcare camps and expand service reach across geographies.

2 more points from QMS Medical Allied Services Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Equipment & Supplies

Ranked on what management guided this quarter

Guidance-ranked
1OSEL Devices
Rev 1Mar 3
Rev 1Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what QMS Medical Allied Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company reported steady revenue growth and continued strong operational execution with a high number of healthcare camps (around 16,000+ in the first half).
  • Saarathi Healthcare acquisition numbers (26% stake acquisition) will be reflected next quarter, indicating upcoming revenue contributions.
  • Discussions and pipelines are ongoing, for example, about 16 programs currently running under Saarathi, with more in the pipeline.

2 more points from QMS Medical Allied Services Ltd's call on order book

Create a free account to keep reading this call

QMS Medical Allied Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

QMS Medical Allied Services Ltd Q2 FY26 results — key figures

QMS Medical Allied Services Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue4537+20.2%47-3.9%
Operating profit (EBITDA)77-4.4%7+5.8%
Operating margin15.48%19.46%-4 pp14.06%+1.4 pp
Profit before tax56-14.5%4+7.8%
Net profit (PAT)44-15.4%3+13.3%
EPS (₹)1.611.90-15.3%1.62-0.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹53 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Equipment & Supplies this season

  • Aprameya Enginee (Q2 FY26)

    H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26

  • Nureca (Q2 FY26)

    Q2 FY26 Revenue from Operations: INR 528 million, a 7% year-on-year (YoY) growth from INR 493 million in Q2 FY25. Key investor presentation takeaways from Nurec

  • Tarsons Products (Q2 FY26)

    Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…

  • Vaidya Sane (Q2 FY26)

    Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. Key concall takeaways from Vaidya Sane's Q2…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

QMS Medical Allied Services Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were QMS Medical Allied Services Ltd Q2 FY26 results?

Product side growth expected around 10% to 12% annually, aligned with pharma industry growth (Page 12). Product segment expected to grow at 10-12% annually, aligned with pharma industry growth.

What is QMS Medical Allied Services Ltd share price analysis?

QMS Medical Allied Services Ltd currently shows a neutral. The stock trades at a P/E of 21.4 with a market cap of ₹216 Cr. Investors should review the full earnings analysis for detailed insights.

Is QMS Medical Allied Services Ltd planning capital expenditure?

The company is investing heavily in infrastructure and people to support growth and improve margins; these investments are expected to show results from next year onwards.

Keep QMS Medical Allied Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.